/Johnson%20%26%20Johnson%20baby%20powder-by%20rafapress%20via%20Shutterstock.jpg)
New Brunswick, New Jersey-based Johnson & Johnson (JNJ) is a healthcare company recognized for its leadership in pharmaceuticals, medical technologies, and consumer health products. Valued at a market cap of $428 billion, the company focuses on improving human health and well-being through scientific innovation, patient-centered care, and a commitment to addressing some of the world’s most pressing health challenges. The company is expected to announce its fiscal Q3 earnings for 2025 before the market opens on Tuesday, Oct. 14.
Before this event, analysts project this healthcare giant to report a profit of $2.78 per share, up 14.9% from $2.42 per share in the year-ago quarter. The company has a promising trajectory of consistently beating Wall Street’s bottom-line estimates in each of the last four quarters. Its earnings of $2.77 per share in the previous quarter topped the consensus estimates by 4.1%.